O manejo do paciente em crise
DOI:
https://doi.org/10.25118/2763-9037.2011.v1.1425Palavras-chave:
transtorno bipolar, depressão, suicídioResumo
.
Downloads
Métricas
Referências
1. ANGST F.; STASSEN HH; CLAYTON PJ; ANGST J. Mor-tality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. v.68. p.167-81. 2002. DOI: https://doi.org/10.1016/S0165-0327(01)00377-9
2. ANGST J; ANGST F; GERBER-WERDER R; GAMMA, A. Suicide in 406 mood-disorder patients with and wi-thout long-term medication: a 40 to 44 years’ follow--up. Arch Suicide Res. v.9. p.279-300. 2005. DOI: https://doi.org/10.1080/13811110590929488
3. Asberg M, Traskman L, Thoren P. 5-HIAA in the cere-brospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 1976;33(10):1193-7. DOI: https://doi.org/10.1001/archpsyc.1976.01770100055005
4. Azorin JM, Bowden CL, Garay RP, Perugi G, Vieta E, Young AH. Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoho-lism. Neuropsychiatr Dis Treat. 2010 Mar 24;6:37-46. DOI: https://doi.org/10.2147/NDT.S6741
5. Baldaçara L, Sanches M, Cordeiro DC, Jackoswski AP. Rapid tranquilization for agitated patients in emer-gency psychiatric rooms: a randomized trial of olanza-pine, ziprasidone, haloperidol plus promethazine, ha-loperidol plus midazolam and haloperidol alone. Rev Bras Psiquiatr. 2011 Mar;33(1):30-9. DOI: https://doi.org/10.1590/S1516-44462011000100008
6. Bauer MS, Mitchner L. What is a “mood stabilizer”? An evidence-based response. Am J Psychiatry. 2004 Jan;161(1):3-18. DOI: https://doi.org/10.1176/appi.ajp.161.1.3
7. Blacker D, Tsuang MT. Contested boundaries of bipo-lar disorder and the limits of categorical diagnosis in psychiatry. Am J Psychiatry. 1992; 149(11):1473-1483 DOI: https://doi.org/10.1176/ajp.149.11.1473
8. Blumenthal SJ. Suicide: a guide to risk factors, asses-sment, and treatment of suicidal patients. Med Clin North Am 1988;72:937–71. DOI: https://doi.org/10.1016/S0025-7125(16)30754-4
9. Brent DA, Mann JJ. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Ge-net, 133:13-24, 20 05. DOI: https://doi.org/10.1002/ajmg.c.30042
10. Brzozowski FS, Soares BG, Benedet J, Boing AF, Peres MA. Suicide time trends in Brazil from 1980 to 2005. Cad. Saúde Pública, Rio de Janeiro, 26(7):1293-1302, jul, 2010. DOI: https://doi.org/10.1590/S0102-311X2010000700008
11. Cavazzoni P, Grof P, Duffy A, Grof E, Mu ̈ ller-Oerlin-ghausen B, Bergho ̈ fer A, Ahrens B, Zvolsky P, Robert-son C, Davis A, Hajek T, Alda M. Heterogeneity of the risk of suicidal behavior in bipolar spectrum disorders. Bipolar Disord 2007: 9: 377–385. DOI: https://doi.org/10.1111/j.1399-5618.2007.00516.x
12. Colom F, and Vieta, E. (2004). Melhorando o desfecho do transtorno bipolar usando estratégias não farma-cológicas: o papel da psicoeducação. Revista Brasileira De Psiquiatria (São Paulo, Brazil : 1999). 26: 47-50. DOI: https://doi.org/10.1590/S1516-44462004000700011
13. COLOM, F., VIETA, E J. SANCHEZ-MORENO, R. PALO-MINO-OTINIANO, M. REINARES, J.M. GOIKOLEA, A. BENABARRE, AND A. MARTINEZ-ARAN. (2009). “Group psychoeducation for stabilised bipolar disor-ders: 5-year outcome of a randomised clinical trial”. The British Journal of Psychiatry. 194 (3): 260-265. DOI: https://doi.org/10.1192/bjp.bp.107.040485
14. Fawcett J, Clark DC, Busch KA. Assessing and tre-ating the patient at risk for suicide. Psychiatr Ann 1993;23:244–55. DOI: https://doi.org/10.3928/0048-5713-19930501-05
15. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970; 263: 455–468 DOI: https://doi.org/10.1016/0021-9681(70)90054-8
16. Fenn HH, Bauer MS, Alshuler L, et al. Medical comor-bidity and health-related quality of life in bipolar di-sorder across the adult age span. J Affect Disord 2005; 86:47– 60. DOI: https://doi.org/10.1016/j.jad.2004.12.006
17. Frank E. Treating Bipolar Disorder: A Clinician’s Gui-de to Interpersonal and Social Rhythm Therapy. New York, NY: Guilford Press; 2005.
18. Fu Q, Heath AC, Bucholz KK, et al. A twin study of genetic and environmental influences on suicidality in men. Psychol Med 32:11-24, 2002. DOI: https://doi.org/10.1017/S0033291701004846
19. Ghaemi SN, Bauer M, Cassidy F et al. Diagnostic guide-lines for bipolar disorder: a summary of the Internatio-nal Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disord 2008; 10: 117–128. DOI: https://doi.org/10.1111/j.1399-5618.2007.00556.x
20. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 2007.
21. Hirschfeld RM, Cass AR, Holt DC, et al. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. 2005;18(4):233–239. DOI: https://doi.org/10.3122/jabfm.18.4.233
22. Hyman S, Chisholm D, Kessler R, Patel V, Whiteford H. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 31.
23. Henderson C, Flood C, Leese M, Thornicroft G, Su-therby K, Szmukler G. Effect of joint crisis plans on use of compulsory treatment in psychiatry: sin-
gle blind randomised controlled trial. BMJ. 2004 Jul 17;329(7458):136 . DOI: https://doi.org/10.1136/bmj.38155.585046.63
24. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002 Jun;59(6):530-7. DOI: https://doi.org/10.1001/archpsyc.59.6.530
25. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB. A pros-pective investigation of the natural history of the long--term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003 Mar;60(3):261-9. DOI: https://doi.org/10.1001/archpsyc.60.3.261
26. KALLNER, G; LINDELIUS, R; PETTERSON, U; STOCK-MAN, O; THAM, A. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry. v.1. n.8-13. 2000. DOI: https://doi.org/10.1055/s-2000-7965
27. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM. Allostatic load in bipolar disorder: Implica-tions for pathophysiology and treatment. Neuroscien-ce and Biobehavioral Reviews 32 (2008) 675–692 DOI: https://doi.org/10.1016/j.neubiorev.2007.10.005
28. Kessler RC, McGonigle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disor-ders in the US: results from the national comorbidity study. Arch Gen Psychiatry 1994; 51:8–19 DOI: https://doi.org/10.1001/archpsyc.1994.03950010008002
29. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001; 158:1091-1098 DOI: https://doi.org/10.1176/appi.ajp.158.7.1091
30. LUOMA, JB; MARTIN, CE; PEARSON, JL. Contact with mental health and primary care providers before suicide:a review of the evidence. Am J Psychiatry. v.159. p.909-916. 2002. DOI: https://doi.org/10.1176/appi.ajp.159.6.909
31. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Europsychopharmacology, 24:467-77, 2001. DOI: https://doi.org/10.1016/S0893-133X(00)00228-1
32. Mann JJ. A Current Perspective of Suicide and Attempt ArtIGo /////////////////// por FERnAnDo SILVA nEVESe HUMBERTo CoRRêA Suicide. Ann Intern Med 136:302-311, 2002 DOI: https://doi.org/10.7326/0003-4819-136-4-200202190-00010
33. McElroy SL, Altshuler LL, Suppes T, Keck PE Jr, Frye MA, Denicoff KD, Nolen WA,Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158(3):420-426 DOI: https://doi.org/10.1176/appi.ajp.158.3.420
34. McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Candy W.Y, Law CW, Miranda Ad, Konarski JZ, Kennedy SH. Medical comorbidity in bipolar disor-der: reprioritizing unmet needs. Current Opinion in Psychiatry 2007, 20:406–416 DOI: https://doi.org/10.1097/YCO.0b013e3281938102
35. Miklowitz DJ, Goldstein MJ. Bipolar Disorder: A Fami-ly-Focused Treatment Approach. New York, NY: Guil-ford Press; 1997.
36. Miklowitz DJ, Otto MW, Frank E et al. Psychosocial treatments for bipolar depression: a 1-year randomi-zed trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 2007; 64: 419–426. DOI: https://doi.org/10.1001/archpsyc.64.4.419
37. Müller-Oerlinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology. 2010;62(1):43-9. DOI: https://doi.org/10.1159/000314309
38. Neves FS, Malloy-Diniz LF, Barbosa IG, Brasil PM, Cor-rêa H. Bipolar disorder first episode and suicidal beha-vior: are there differences according to type of suicide attempt? Rev Bras Psiquiatr. 2009 Jun;31(2):114-8. DOI: https://doi.org/10.1590/S1516-44462009000200006
39. Oquendo MA, Mann JJ. Identifying and managing sui-cide risk in bipolar patients. J Clin Psychiatry 62 (sup-pl):31-34, 2001.
40. Osby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58:844–850. DOI: https://doi.org/10.1001/archpsyc.58.9.844
41. Otto MW, Reilly-Harrington NA. Cognitive-behavior therapy for the management of bipolar disorder. In: Hofmann SG, Tompson MC, eds. Handbook of Psychosocial Treatments for Severe Mental Disorders. New York, NY: Guilford Press; 2002:116-130.
42. Perlis RH, Ostacher MJ, Patel JK et al. Predictors of re-currence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for
43. Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163: 217–224. DOI: https://doi.org/10.1176/appi.ajp.163.2.217
44. Petresco S, Gutt EK, Krelling R, Lotufo Neto F, Rohde LA, Moreno RA. The prevalence of psychopathology in offspring of bipolar women from a Brazilian tertiary center. Rev Bras Psiquiatr. 2009 Sep;31(3):240-6. DOI: https://doi.org/10.1590/S1516-44462009000300009
45. POKORNY, AD. Prediction of suicide in psychiatric patients: report of a prospective study. Arch. Gen. Psychiatry. v.40. p.249–257. 1983. DOI: https://doi.org/10.1001/archpsyc.1983.01790030019002
46. Prien RF, Potter WZ. NIMH workshop report on tre-atment of bipolar disorder. Psychopharmacol Bull 1990;/26:/409-27.
47. Rocca CC, Lafer B. Neuropsychological disturbances in bipolar disorder. Rev Bras Psiquiatr. 2006 Sep;28(3):226-37. DOI: https://doi.org/10.1590/S1516-44462006000300016
48. Rosen C, Grossman LS, Harrow M. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophre-nia and bipolar disorder. Comprehensive Psychiatry 52 (2011) 126 –131. DOI: https://doi.org/10.1016/j.comppsych.2010.06.005
49. Ruchlewska A, Mulder CL, Smulders R, Roosenscho-on BJ, Koopmans G, Wierdsma A. The effects of crisis plans for patients with psychotic and bipolar disorders: a randomised controlled trial. BMC Psychiatry. 2009 Jul 9;9:41. DOI: https://doi.org/10.1186/1471-244X-9-41
50. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, Maggini C. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first--episode psychotic disorder patients. J Clin Psychiatry. 2009;70(4):458-66. DOI: https://doi.org/10.4088/JCP.08m04227
51. Shatiel G, Chen G e Manji HK. Neurotrophic signaling cascades in the pathophysiology and treatment of bi-polar disorder. Current Opinion in Pharmacology 2007, 7:22–26 DOI: https://doi.org/10.1016/j.coph.2006.07.005
52. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sag-duyu K, Frank E, Sachs GS, Anxiety disorder comor-bidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhan-cement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161:2222-2229 DOI: https://doi.org/10.1176/appi.ajp.161.12.2222
53. Singh JB, Zarate Jr CA. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials. Bipolar Disord 2006: 8: 696–709. DOI: https://doi.org/10.1111/j.1399-5618.2006.00371.x
54. Stathan DJ, Heath AC, Madden PAF, et al. Suici-dal behavior: an epidemiological and genetic study. Psychol Med 28:838-855, 1998. DOI: https://doi.org/10.1017/S0033291798006916
55. Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Ge-bre-Medhin P, Cohen BM. Two-year syndromal and functional recovery in 219 cases of first-episode ma-jor affective disorder with psychotic features. Am J Psychiatry. 2000 Feb;157(2):220-8. DOI: https://doi.org/10.1176/appi.ajp.157.2.220
56. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP. he expert consensus guideli-ne series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70 Suppl 4:1-46; DOI: https://doi.org/10.4088/JCP.7090su1cj
57. Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Be-aulieu S, O_Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A,Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese JR,Berk M, Ha K, Kap-czinski F. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CAN-MAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009: 11: 225–255. DOI: https://doi.org/10.1111/j.1399-5618.2009.00672.x
58. YEREVANIAN, BI; KOEK, RJ; MINTZ, J. Lithium, anti-convulsants and suicidal behavior in bipolar disorder. J Affect Disord. v.73. p.223-8. 2003. DOI: https://doi.org/10.1016/S0165-0327(02)00302-6
59. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression re-presentative of patients in routine clinical practice? Am J Psychiatry, 159:469-73, 2002. DOI: https://doi.org/10.1176/appi.ajp.159.3.469
60. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Psychiatric diagnoses in patients previously overdiag-nosed with bipolar disorder. J Clin Psychiatry. 2010 Jan;71(1):26-31.ArtIGo /////////////////// por FERnAnDo SILVA nEVESe HUMBERTo CoRRêA DOI: https://doi.org/10.4088/JCP.08m04633
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2011 Fernando Silva Neves, Humberto Corrêa da Silva Filho
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria permite que o (s) autor (es) mantenha(m) seus direitos autorais sem restrições. Atribuição-NãoComercial 4.0 Internacional (CC BY-NC 4.0) - Debates em Psiquiatria é regida pela licença CC-BY-NC
